Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present AEterna Zentaris Inc. (NASDAQ: AEZS).

Full DD Report for AEZS

You must become a subscriber to view this report.


Recent News from (NASDAQ: AEZS)

Aeterna Zentaris Inc.'s (AEZS) CEO Michael Ward on Q2 2018 Results - Earnings Call Transcript
AEterna Zentaris, Inc. (AEZS) Q2 2018 Results Earnings Conference Call August 10, 2018, 08:30 AM ET Executives Michael Ward - CEO James Clavijo - CFO Nicola Ammer - Chief Medical Officer Brian Garrison - SVP, Global Commercial Operations Analysts Ramakanth Swayampakula - ...
Source: SeekingAlpha
Date: August, 10 2018 10:18
Aeterna Zentaris beats by $0.16, misses on revenue
Aeterna Zentaris (NASDAQ: AEZS ): Q2 EPS of -$0.16 beats by $0.16 . Revenue of $0.17M (-29.2% Y/Y) misses by $1.83M . Cash of $19.9M. Press Release More news on: AEterna Zentaris, Inc., Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: August, 09 2018 16:58
Aeterna Zentaris Reports Second Quarter 2018 Financial and Operating Results
CHARLESTON, S.C., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS)  (TSX: AEZS), a biopharmaceutical company engaged in developing and commercializing pharmaceutical products, today reported financial and operating results for the second quarter ended June 30, ...
Source: GlobeNewswire
Date: August, 09 2018 16:18
Aeterna Zentaris to Announce Second Quarter 2018 Financial and Operating Results on August 9, 2018
CHARLESTON, S.C., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX: AEZS) will announce its second quarter 2018 financial and operating results after market close on Thursday, August 9, 2018. The Company will host a conference call to discuss these results on Fri...
Source: GlobeNewswire
Date: August, 02 2018 16:05
Key events next week - healthcare
Noteworthy events during the week of June 17 - 23 for healthcare investors. More news on: Matinas Biopharma Holdings, Inc., Valeant Pharmaceuticals International, Inc., Sarepta Therapeutics, Inc., Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: June, 15 2018 15:31
Aeterna Zentaris Appoints Olaf Althaus as General Manager and Managing Director of Aeterna Zentaris GmbH
CHARLESTON, S.C., May 31, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) announced that Olaf Althaus has been appointed to the position of General Manager and Managing Director of Aeterna Zentaris GmbH in  Frankfurt, Germany, effective June 1, 2018. Mr. Altha...
Source: GlobeNewswire
Date: May, 31 2018 16:15
Midday Gainers / Losers (05/31/2018)
Gainers:   MDGL +141% . VKTX +68% . TPIV +24% . SESN +25% . CRIS +22% . VTVT +21% . JILL +21% . BOXL +19% . AXON +17% . I +17% . More news on: Madrigal Pharmaceuticals, Inc., Viking Therapeutics, TapImmune, Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: May, 31 2018 12:45
Week 22 Breakout Forecast: Short-Term Picks To Give You An Edge
Breakout Forecast Selections for Week 22: Market conditions continue with high volatility. The positive momentum gauge spent another full week in yellow (medium) moving from a value of 73 last week down to a value of 57 this week. The all time low for the positive momentum selection gauge is...
Source: SeekingAlpha
Date: May, 27 2018 01:30
Aeterna Zentaris Announces Results of Annual and Special Shareholders' Meeting
CHARLESTON, S.C., May 08, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) announced today at its annual and special shareholders’ meeting held on May 8, 2018, that the individuals noted below were elected as directors of the Company. The report on proxies prov...
Source: GlobeNewswire
Date: May, 08 2018 16:15
Aeterna Zentaris' (AEZS) CEO Michael V. Ward on Q1 2018 Results - Earnings Call Transcript
Aeterna Zentaris Inc. (AEZS) Q1 2018 Results Earnings Conference Call May 08, 2018 08:30 AM ET Executives Michael V. Ward - CEO James Clavijo - CFO Analysts Olga Smolentseva - H.C. Wainwright Presentation Operator Greetings and welcome to Aeterna Zentaris Reports Fi...
Source: SeekingAlpha
Date: May, 08 2018 12:02

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-113.603.32193.603.32300,828
2018-12-103.703.523.7253.45439,833
2018-12-073.693.63383.723.56193,734
2018-12-063.613.693.703.20631,788
2018-12-053.923.663.923.39673,823

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1145,150118,26738.1763Short
2018-12-1089,169164,25554.2869Short
2018-12-0713,03762,37420.9013Cover
2018-12-06118,524262,58045.1382Short
2018-12-0489,266215,06141.5073Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AEZS.


About AEterna Zentaris Inc. (NASDAQ: AEZS)

Logo for AEterna Zentaris Inc. (NASDAQ: AEZS)

Not available

 

Contact Information

 

 

Current Management

  • Gilles Gagnon / President, CEO
  • Jurgen Engel / COO
  • Mario Maradis / Secretary

Current Share Structure

  • Market Cap: $30,579,814 - 05/14/2018
  • Issue and Outstanding: 16,440,760 - 12/31/2017

 


Recent Filings from (NASDAQ: AEZS)

Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: May, 08 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 08 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 08 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 07 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 07 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 01 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: April, 09 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: April, 09 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 28 2018
Annual and transition report of foreign private issuers under sections 13 or 15(d)
Filing Type: 20-FFiling Source: edgar
Filing Date: March, 28 2018

 

 


Daily Technical Chart for (NASDAQ: AEZS)

Daily Technical Chart for (NASDAQ: AEZS)


Stay tuned for daily updates and more on (NASDAQ: AEZS)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: AEZS)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AEZS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of AEZS and does not buy, sell, or trade any shares of AEZS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/